The Next Evidence Standard for Food Enzymes · Why EFSA's November 2026 reassessment of animal toxicology and allergen bioinformatics could reshape enzyme development, manufacturing specifications and cross-border market access
Year: 2026
Type: article
Abstract: The European Food Safety Authority is preparing to revisit two pillars of food-enzyme risk assessment: repeated-dose systemic toxicity studies and the interpretation of amino-acid sequence matches to known allergens. Its stakeholder meeting of 25–26 November 2026 is a timely signal of methodological change, not an enacted relaxation of safety requirements. This article examines the scientific case for reducing redundant animal studies, the limitations of conventional allergen-homology screening, and the more demanding question of whether enzyme preparations can be characterised sufficiently to support reliable, proportionate decisions. It connects production-strain genomics, total organic solids, residual activity, exposure modelling, fermentation impurities, process validation and post-market governance. The comparative analysis distinguishes the European Union and Spain from Great Britain and the United States, where evidence can travel but authorisations do not automatically follow. A research agenda proposes a transparent, uncertainty-calibrated assessment architecture that could reduce unnecessary testing without transferring hidden risks to consumers or manufacturers.
Author: López, José M.
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236479058
